Insiders · LXRX

Michael Exton

Chief Executive Officer, Director at Lexicon Pharmaceuticals, Inc. (LXRX) since July 2024

Michael Exton has filed 6 insider reports with the SEC since July 2024, as chief Executive Officer and director at Lexicon Pharmaceuticals, Inc. (LXRX). In the last 12 months Michael Exton bought $50K of stock on the open market. In the latest filing, on November 9, 2026, Michael Exton bought 30,064 shares of Lexicon Pharmaceuticals, Inc. (LXRX) for $50K at an average of $1.66.

Filings
6
Companies
1
Bought on market
$50K
Sold on market
None

Companies where Michael Exton is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
Lexicon Pharmaceuticals, Inc. logo
LXRX
Lexicon Pharmaceuticals, Inc.
Chief Executive Officer, Directorsince July 2024328,496$50K$1.66$1.53-7.8%Nov 9, 2026

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record. Price now: the latest daily close, against the average buy price.

Every filing

Compare Michael Exton with

Other insiders at the same companies

Questions about Michael Exton

What is Michael Exton's role at Lexicon Pharmaceuticals, Inc.?
Michael Exton reports to the SEC as chief Executive Officer and director at Lexicon Pharmaceuticals, Inc. (LXRX), according to the latest filing on November 9, 2026.
How many shares does Michael Exton own?
After the latest filing that states it, Michael Exton directly owned 328,496 shares of Lexicon Pharmaceuticals, Inc. (LXRX). Shares held through trusts, funds or family members are reported separately and are not counted here.
Has Michael Exton bought or sold stock recently?
The most recent open-market purchase was on November 6, 2026: bought 30,064 shares of Lexicon Pharmaceuticals, Inc. (LXRX) for $50K at an average of $1.66.
How do I get alerts when Michael Exton files?
Follow Michael Exton on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale. Michael Exton filed 1 time in the last 90 days.

From SEC Forms 3, 4, 5 and 144 filed by Michael Exton (SEC CIK 0002029249). Totals count each trade once, skipping amendments whose original is on file, from Jul 8, 2024 on. View on SEC EDGAR · Get this as JSON